Content uploaded by Karsten Schöller
Author content
All content in this area was uploaded by Karsten Schöller on Jul 25, 2017
Content may be subject to copyright.
Standardized induction of subarachnoid hemorrhage in mice by
intracranial pressure monitoring – Characterization of the model
Sergej Feiler*, Benjamin Friedrich*, Karsten Schöller, Serge C. Thal, and Nikolaus Plesnila
Institute for Surgical Research and Department of Neurosurgery, University of Munich
Medical Center - Grosshadern, Marchioninistr. 15, 81377 Munich, Germany
*both authors contributed equally to this work
Address of correspondence:
Prof. Nikolaus Plesnila
Royal College of Surgeons in Ireland (RCSI)
123 St. Stephen’s Green,
Dublin 2, Ireland,
Phone: +353 1 402 2794,
E-mail: nikolausplesnila@rcsi.ie
Feiler et al., Brain damage and ICP after SAH in mice
ABSTRACT
Background and Purpose: Subarachnoid hemorrhage (SAH) is the subtype of stroke with
the most unfavorable outcome but the least well investigated molecular pathophysiology.
Among others, not sufficiently well standardized in vivo models suitable for the use with
transgenic animals may be responsible for this situation. Therefore the aim of the current
study was to detect suitable intra-operative parameters for the controlled and standardized
induction of SAH in mice and to characterize the long-term functional and histopathological
outcome of mice subjected to this procedure.
Methods: Experimental study in mice using the intraluminal Circle of Willis perforation (CWp)
model of SAH.
Results: SAH induced a sharp increase of intracranial pressure (ICP) from 5.1 ± 1.2 to 78.5
± 9.3 mmHg (mean +/- SD; p<0.05), a concomitant drop of cerebral blood flow (rCBF) by 81
± 4% (p<0.05), and a significant Cushing reflex response (p<0.05). rCBF measurements
alone could not reliably detect SAH. SAH resulted in significant brain edema formation (brain
water content increase at 72 h: 2.9 ± 0.9%; p<0.05), loss of hippocampal neurons (CA1: -
56%, CA2: -55%; CA3:-72%; 7 days; p<0.05), severe neurological dysfunction over 7 days,
and a mortality of 30%.
Conclusions: Our results indicate that CWp in mice can be standardized by intra-operative
ICP monitoring. CWp leads to prolonged intracranial hypertension, selective neuronal cell
death in the hippocampus, and severe neurological dysfunction. CWp in mice with ICP
monitoring may therefore become a valuable tool for future investigations of the molecular
pathophysiology of SAH.
Keywords: SAH – mouse – intracranial pressure – neuronal cell death – functional outcome
2
Feiler et al., Brain damage and ICP after SAH in mice
1. Background
Cerebral hemorrhages cause only 20% of all strokes but are responsible for ~50% of the
entire stroke-related mortality, i.e. hemorrhagic stroke is 4.5 times more fatal than ischemic
stroke (Rosamond, Folsom et al., 1999). One of the most common and severe causes for
hemorrhagic stroke is subarachnoid hemorrhage (SAH), a bleeding from a large extra-
parenchymal cerebral vessel mostly caused by a ruptured congenital aneurysm. SAH has an
over all mortality of about 50% and over 30% of survivors remain severely disabled (van Gijn
and Rinkel, 2001). Despite these facts and some pathophysiological similarities, SAH is by
far less frequently investigated than ischemic stroke. Consequently, several important
aspects of the pathophysiology of SAH, especially on the molecular level, are not well
defined thereby hampering the development of novel therapeutic strategies (Cahill and
Zhang, 2009). One of the reasons responsible for this situation may be that murine models of
SAH which can be used with transgenic animals have so far not been fully characterized and
standardized (Strbian, Durukan et al., 2008). To date important clinical parameters such as
intracranial pressure and neuropathology have not been investigated following experimental
SAH in mice. In contrast to other well standardized murine models of acute brain injury, e.g.
ischemic stroke, successful induction and the severity of the insult are not monitored intra-
operatively leading to heterogeneous results which can only be compensated with group
sizes not easily compatible with difficult to generate transgenic mouse strains and by grading
the severity of experimental SAH only post-hoc (Gao, Wang et al., 2006;Sozen, Tsuchiyama
et al., 2009). This makes a randomized study design difficult to achieve and limits the value
of these otherwise clinically highly relevant animal models significantly (Strbian, Durukan et
al., 2008).
So far several research groups studied SAH in mice either by perforating the Circle of Willis
at the skull base using an intraluminal filament inserted through the external carotid artery
(Kamii, Kato et al., 1999;Sozen, Tsuchiyama et al., 2009;Ishikawa, Kusaka et al., 2009;Liu,
Tang et al., 2007;McGirt, Parra et al., 2002;Parra, McGirt et al., 2002;Saito, Kamii et al.,
3
Feiler et al., Brain damage and ICP after SAH in mice
2001;Gao, Wang et al., 2006;McGirt, Lynch et al., 2002), by directly injecting blood into the
cisterna magna (Lin, Calisaneller et al., 2003), or by perforating an intracisternal vein (Altay,
Smithason et al., 2009). Since perforation of an intracerebral vessel by a filament resembles
aneurysmal hemorrhage closer than intraventricular injection of blood, Circulus of Willis
perforation (CWp) became the most widely used SAH model in mice. Pioneering studies
using CWp demonstrated delayed cerebral vasospasm (Gao, Wang et al., 2006;Kamii, Kato
et al., 1999;McGirt, Parra et al., 2002;McGirt, Lynch et al., 2002;Parra, McGirt et al.,
2002;Saito, Kamii et al., 2001), neurological dysfunction (Gao, Wang et al., 2006;McGirt,
Parra et al., 2002;McGirt, Lynch et al., 2002;Parra, McGirt et al., 2002;Liu, Tang et al.,
2007;Sozen, Tsuchiyama et al., 2009), brain edema formation (Liu, Tang et al., 2007;Sozen,
Tsuchiyama et al., 2009), and a clinically relevant mortality of ~30% (Gao, Wang et al.,
2006;Liu, Tang et al., 2007;Sozen, Tsuchiyama et al., 2009). So far, however, it remains
unclear how the initial bleeding is linked to these rather late and severe pathophysiological
findings since it is not known if experimental SAH in mice causes intracranial hypertension,
reduces cerebral perfusion pressure, and causes subsequent ischemic brain damage.
Therefore, the aim of the current study was to characterize intracranial pressure (ICP),
cerebral perfusion pressure (CPP), cerebral blood flow (CBF), and neuronal cell death
following experimental SAH and to identify intra-operative monitoring parameters (ICP, CBF)
which may help to further standardize Circle of Willis perforation in mice.
4
Feiler et al., Brain damage and ICP after SAH in mice
2. Materials and methods
Male C57Bl6 mice (23 to 25 g body weight; Charles River Laboratory, Sulzfeld, Germany)
were used for experiments according to the guidelines of the Animal Care Committee of the
District Government of Upper Bavaria (Protocol Number Az 55.2-1-54-2531-118-05).
2.1. Animal preparation and monitoring
Animals had free access to food and water prior to and after surgery. Anesthesia was
induced by intraperitoneal injection of midazolam (5 mg/kg; Ratiopharm, Ulm, Germany),
fentanyl (0.05 mg/kg; CuraMed, Karlsruhe, Germany), and medetomidin (0.5 mg/kg; Pfizer,
Germany) and maintained by hourly injections of one quarter of the initial dose as previously
described (Thal and Plesnila, 2007). Mice were intubated and mechanically ventilated with
35-38% O2 in room air (Minivent, Hugo Sachs, Hugstetten, Germany). End-tidal pCO2 was
measured on-line with a microcapnometer (CI240, Columbus Instruments, Columbus, USA).
A thermostatically regulated, feedback-controlled heating pad (FHC, Bowdoinham, USA) was
used to maintain rectal temperature at 37°C. Anesthesia was terminated by intraperitoneal
injection of atipamezol (2.5 mg/kg; Pfizer, Karlsruhe, Germany), naloxon (1.2 mg/kg; Inresa,
Freiburg, Germany), and flumazenil (0.5 mg/kg; Hoffmann-La-Roche, Grenzach-Wyhlen,
Germany). To prevent hypothermia animals were kept in an incubator at 33°C ambient
temperature for 24 hours after surgery.
2.2. ICP measurement and laser-Doppler flowmetry
ICP was continuously measured in the epidural space of the right hemisphere from 40
minutes before until 30 minutes after SAH using a Codman ICP microsensor (Johnson &
Johnson Medical Limited, Berkshire, UK). To assess ICP 24 and 72 hours after SAH animals
were re-anesthetized, intubated, and the ICP probe was placed for 10 minutes into the
epidural space as described above.
For continuous monitoring of regional cerebral blood flow (rCBF) a flexible laser-Doppler
probe (Periflux 4001 Master, Perimed, Stockholm, Sweden) was glued onto the skull above
the territory of the left middle cerebral artery (MCA). rCBF was measured at a sampling rate
5
Feiler et al., Brain damage and ICP after SAH in mice
of 10 Hz from 30 minutes before until 30 minutes after SAH. The LDF probe was removed at
the end of surgery.
2.3. Induction of SAH by endovascular filament perforation
SAH was induced by a modification of the endovascular filament perforation method that has
been described in rats and mice previously (Bederson, Germano et al., 1995;Kamii, Kato et
al., 1999;Parra, McGirt et al., 2002). Briefly, animals were anesthetized and placed in a
supine position. The neck was opened by a midline incision and the left carotid artery was
exposed. A 5-0 monofilament was advanced via the external carotid artery (ECA) into the
internal carotid artery (ICA) until the ipsilateral rCBF decreased to ensure the position of the
tip of the filament near the bifurcation of the ICA and the MCA. Then the filament was pushed
further until a sharp increase in ICP indicated the successful induction of SAH. Subsequently,
the suture was withdrawn into the ECA to allow full perfusion of the ICA. In sham operated
animals the same procedure was performed, i.e. the suture was introduced in the ICA,
without causing a rCBF decrease and SAH.
2.4. Neuroscore and body weight
Neurological deficits were assessed daily for 7 days by an investigator blinded towards the
treatment of the animals. Neurological deficits were quantified using a neuroscore as
previously described (Lehmberg, Beck et al., 2000) (Tab. 2). Mice with no neurological
deficits received a score of 0 points, animals with the most severe loss of neurological
function a score of 33 points. Body weight, a sensitive indicator for the overall well-being of
rodents, was assessed daily for 7 days using a balance with movement artifact correction
(Mettler-Toledo, Giessen, Germany).
2.5. Quantification of Cerebral Edema
Animals were sacrificed 24 or 72 hours after SAH and the wet weight (WW) of both
hemispheres was assessed. Thereafter, the hemispheres were dried for 24 h at 110°C and
their dry weight (DW) was determined. Hemispheric water content (%) was calculated using
the following formula ((WW-DW) / WW) x 100.
6
Feiler et al., Brain damage and ICP after SAH in mice
2.6. Quantification of Ischemic Brain damage
Animals were anesthetized and transcardially perfused with 2% paraformaldehyde (PFA) 7
days after SAH. Brains were removed, dehydrated, and embedded in paraffin. Coronal
sections (bregma -1.6 mm) were prepared and stained with Cresyl Violet. The number of
surviving neurons in the hippocampus was quantified in a region of interest of 0.4 x 0.4 mm
as previously described (Bermueller, Thal et al., 2006).
2.7. Experimental groups
In a first experimental series physiological parameters were assessed and the neurological
function was assessed for 7 days after SAH or sham surgery (n=6 each). In a parallel series
mortality was quantified in SAH and sham operated mice (n=10 per group). In a second
series ICP was measured 24 or 72 hours after SAH or in sham operated animals (n=6 each).
In a third series brain water content was measured 24 or 72 hours after SAH or in sham
operated animals (n=6 each). In a fourth series ischemic neuronal damage was assessed in
sham operated animals or 7 days after SAH (n=6 each). Accordingly, 80 animals were
included in the current analysis.
Animals that died during and after the operation were replaced until the final group size was
n=6. In the series where mortality was assessed animals were not replaced.
2.8. Statistical Analysis
Data are presented as means ± SEM if not indicated otherwise. Statistical analysis was
performed with the software package SigmaStat 3.1 (SPSS Science Inc., Chicago, IL, USA).
Data over time were analyzed with Kruskal-Wallis ANOVA on ranks. The Student-Newman-
Keuls Test was used for multiple comparisons. Mortality was compared between groups with
the Survival Log Rank Test. Statistical significance was assumed at p<0.05.
7
Feiler et al., Brain damage and ICP after SAH in mice
3. RESULTS
3.1. Physiological Parameters
SAH by filament perforation resulted in an immediate increase of ICP to a peak of 78.5 ± 9.3
mmHg (p<0.05 vs. baseline) followed by a plateau that was reached between 5 minutes
(39.6 ± 8.4 mmHg) and 10 minutes (20.0 ± 3.6 mmHg) after SAH. In sham-operated animals,
ICP remained around the physiological level of 5.0 ± 0.5 mmHg for the whole monitoring
period (Fig. 1A). The increase in ICP resulted in an immediate increase of mean arterial
blood pressure (p<0.05 vs. sham), the well known Cushing response (Fig. 1B), in a
significant drop in cerebral perfusion pressure (CPP) down to 25 mmHg (p<0.05 vs. sham;
Fig. 1C), and the subsequent reduction of cerebral blood flow (CBF) to ischemic levels (19 ±
4% of baseline; p<0.05 vs. sham; Fig. 1D). After ICP dropped to values around 20 mmHg
CCP normalized and CBF recovered to normal values of 80 ± 9.8% of baseline. Except the
Cushing response mice subjected to SAH or sham surgery did not differ concerning blood
pressure and blood gases (Tab. 1).
Vessel perforation resulted in a hematoma at the perforation site (Fig. 1E, dotted circle) and
in a significant extravasation of blood into the subarachnoid space of both hemispheres (Fig.
1E) indicating severe SAH. These changes were only observed when advancement of the
filament into the Circle of Willis was accompanied by a sharp increase in ICP. An isolated
drop in CBF, a method proposed to be useful for monitoring SAH induction in mice, did not
necessarily result in SAH as evidenced by simultaneous ICP measurements (Fig. 1F) and
subsequent visual inspection of blood extravasation. Therefore, ICP measurements are
mandatory in order to reliably monitor experimental SAH in mice.
3.2. Mortality
One animal of the filament perforation group died on postoperative day 1 and another 2
animals died on postoperative day 2 (30% mortality). There was no mortality in sham
operated animals (n=10 each; Fig. 2A).
8
Feiler et al., Brain damage and ICP after SAH in mice
3.3. Cerebral Edema
SAH by filament perforation resulted in a significant (p<0.05) and continuous increase of
brain water content in both hemispheres up to 72 hours after SAH (Fig. 2B).
3.4. Chronic ICP-Measurement
Brain edema formation resulted in significant intracranial hypertension 24 hours after SAH
(10.0 ± 0.7 mmHg; p<0.05; Fig. 2C). Three days after SAH ICP returned to normal values.
3.5. Brain Damage
SAH in mice did not result in infarction but in selective, bilateral neuronal loss in the
hippocampus (Fig. 3A). Quantification of the number of viable hippocampal neurons 7 days
after SAH revealed a significant loss (p<0.05) of neurons in all regions of the hippocampus
as compared to sham operated controls. The most severe loss was observed in the
ipsilateral CA3 region (Fig. 3B). No cell death was observed in the cerebral cortex or in the
striatum (Fig. 3C).
3.6. Neurological Evaluation and Body Weight
SAH resulted in severe motor and behavioral deficits (15 out of 33 points) during the first 3
days after SAH. Thereafter mice gradually but incompletely recovered until the end of the
observation period as compared to sham operated animals (p<0.05; Fig. 4A). In addition to
the neurological deficits mice of the SAH group exhibited a significant and long lasting loss of
body weight (- 20%) with only minimal recovery (p<0.001; Fig. 4B).
9
Feiler et al., Brain damage and ICP after SAH in mice
4. DISCUSSION
In the current study we characterized the pattern of brain damage after filament perforation-
induced SAH in mice and demonstrate that the measurement of intracranial pressure is the
only parameter able to reliably detect the induction of SAH by filament perforation.
So far most animals models of SAH were performed on rats, rabbits, cats, or primates (Barry,
Gogjian et al., 1979;Delgado, Brismar et al., 1985;Dorsch, Branston et al., 1989). Despite
multiple advantages, e.g. availability, size, or available standardized models, these species
have, in contrast to mice, the inherent disadvantage of not being amenable to genetic
manipulation. Therefore several groups developed murine SAH models by directly injecting
blood into the cisterna magna (Lin, Calisaneller et al., 2003), dissecting an intracisternal vein
(Altay, Smithason et al., 2009), or perforating an artery at the skull base by introducing a
filament into the cerebral circulation through an extra-cranial approach (Kamii, Kato et al.,
1999;Sozen, Tsuchiyama et al., 2009;Ishikawa, Kusaka et al., 2009;Liu, Tang et al.,
2007;McGirt, Parra et al., 2002;Parra, McGirt et al., 2002;Saito, Kamii et al., 2001;Gao,
Wang et al., 2006;McGirt, Lynch et al., 2002). The cisterna magna injection model and the
venous dissection model can be performed quickly, are highly reproducible due to the
controlled application of the blood, result in an acute increase of ICP and subsequent
decrease of CBF, and lead the development of brain edema and intracranial hypertension as
also observed in man (Broderick, Brott et al., 1994;Claassen, Carhuapoma et al., 2002).
However, both models lack ruptured vessels and endothelial damage which are important
factors of the pathology of SAH (Sobey and Faraci, 1998). Therefore several groups, in
analogy to a model used in rats, developed a murine model where the Circulus of Willis
(CWp) is perforated by an intraluminal filament introduced through the carotid artery. Due to
the obvious replication of the human pathophysiology this model quickly became the most
frequently and widely used experimental SAH model in mice (Kamii, Kato et al., 1999;Sozen,
Tsuchiyama et al., 2009;Ishikawa, Kusaka et al., 2009;Liu, Tang et al., 2007;McGirt, Parra et
al., 2002;Parra, McGirt et al., 2002;Saito, Kamii et al., 2001;Gao, Wang et al., 2006;McGirt,
10
Feiler et al., Brain damage and ICP after SAH in mice
Lynch et al., 2002). CWp causes delayed cerebral vasospasm (Gao, Wang et al.,
2006;Kamii, Kato et al., 1999;McGirt, Parra et al., 2002;McGirt, Lynch et al., 2002;Parra,
McGirt et al., 2002;Saito, Kamii et al., 2001), neurological dysfunction (Gao, Wang et al.,
2006;McGirt, Parra et al., 2002;McGirt, Lynch et al., 2002;Parra, McGirt et al., 2002;Liu,
Tang et al., 2007;Sozen, Tsuchiyama et al., 2009), brain edema (Liu, Tang et al.,
2007;Sozen, Tsuchiyama et al., 2009), and a clinically relevant mortality of ~30% (Gao,
Wang et al., 2006;Liu, Tang et al., 2007;Sozen, Tsuchiyama et al., 2009). CWp has however,
also some significant disadvantages. So far clinically and pathophysiologically important
findings linking these late changes to the initial bleeding such as intracranial pressure and
neuronal damage were not investigated and CWp has the inherent problem that the volume
of intracranial blood can neither be controlled nor monitored. Accordingly, so far CWp falls
short fulfilling the first and second criteria of an ideal SAH model proposed by Schwartz et al.
which are 1) reproducible and consistent blood deposition in the subarachnoid space 2)
uniform, controlled degree of hemorrhage 3) mechanism of hemorrhage closely simulating
aneurysmal SAH 4) blood distribution correlating with aneurysmal SAH 5) ease of
performance and 6) reasonable costs (Schwartz, Masago et al., 2000). Our results clearly
show that monitoring cerebral blood flow is not sufficient to detect successful induction of
SAH since already the advancement of the filament into the internal carotid artery may cause
a drop of CBF without an increase of intracranial pressure (Fig. 1F). Accordingly, the
increase of intracranial pressure, which is a direct measure for the space occupying effect of
the nascent intracranial hematoma, is the only reliable parameter necessary to be recorded
in order to correctly detect induction of SAH in mice. Since the ICP increase and the absolute
ICP values following SAH are very uniform and show little scattering, we conclude that also
the amount of extravasated blood is quite uniform in mice. Hence, CWp exerts many, if not
all, criteria claimed to be important for experimental SAH (see above).
So far the pattern of SAH induced brain damage was not known in mice. Our results indicate
that CWp in mice causes mainly damage to the hippocampus while the cortex and the
11
Feiler et al., Brain damage and ICP after SAH in mice
striatum are not significantly affected. Interestingly, except of the ipsilateral CA3 region which
is most severely damaged, cell death affects both hippocampi equally. This indicates that
either cell death is caused by the initial global increase of ICP and subsequent global
ischemia or that the extravasated blood is distributed in a very uniform fashion within the
subarachnoid space thereby causing acute vasospasm and a subsequent reduction of
cerebral blood flow in both hemispheres. We favor the latter explanation due to the actually
demonstrated quite even distribution of blood in the subarachnoid space (Fig. 1E) and some
recent results in man indicating ICP-independent early ischemia after SAH (Schubert, Seiz et
al., 2009). However, only additional experiments measuring absolute levels of CBF with high
spatial resolution by 14C-iodoantipyrene autoradiography at different time points after CWp
and performing experiments on craniotomized animals which will not display the initial ICP
peak will finally prove this hypothesis.
5. Conclusion
Taken together, the current study characterizes the pattern of neuronal damage following the
intraluminal perforation SAH model in mice and demonstrates that the measurement of
intracranial pressure is the only parameter which reliable detects the induction of SAH. The
results of the current study further characterize and standardize the most widely used model
of murine SAH and help to pave the way for further investigations of the molecular
mechanisms of SAH-induced brain damage by using transgenic animals.
12
Feiler et al., Brain damage and ICP after SAH in mice
RERERENCES
Rosamond WD, Folsom AR, Chambless LE, Wang CH, McGovern PG, Howard G, Copper
LS, Shahar E. Stroke incidence and survival among middle-aged adults: 9-year follow-up of
the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke., 1999; 30: 736-43.
van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management.
Brain, 2001; 124: 249-78.
Cahill J, Zhang JH. Subarachnoid hemorrhage: is it time for a new direction? Stroke., 2009;
40: S86-S87.
Strbian D, Durukan A, Tatlisumak T. Rodent models of hemorrhagic stroke. Curr. Pharm.
Des., 2008; 14: 352-8.
Gao J, Wang H, Sheng H, Lynch JR, Warner DS, Durham L, Vitek MP, Laskowitz DT. A
novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine
model of subarachnoid hemorrhage. Neurocrit. Care., 2006; 4: 25-31.
Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa S, Zhang JH. Role of
interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke., 2009;
40: 2519-25.
Kamii H, Kato I, Kinouchi H, Chan PH, Epstein CJ, Akabane A, Okamoto H, Yoshimoto T.
Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice
overexpressing CuZn-superoxide dismutase. Stroke, 1999; 30: 867-71.
Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa S, Zhang JH. Role of
interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke., 2009;
40: 2519-25.
13
Feiler et al., Brain damage and ICP after SAH in mice
Ishikawa M, Kusaka G, Yamaguchi N, Sekizuka E, Nakadate H, Minamitani H, Shinoda S,
Watanabe E. Platelet and leukocyte adhesion in the microvasculature at the cerebral surface
immediately after subarachnoid hemorrhage. Neurosurgery., 2009; 64: 546-53.
Liu S, Tang J, Ostrowski RP, Titova E, Monroe C, Chen W, Lo W, Martin R, Zhang JH.
Oxidative stress after subarachnoid hemorrhage in gp91phox knockout mice. Can. J. Neurol.
Sci., 2007; 34: 356-61.
McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, Pearlstein RD, Warner DS.
Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing
extracellular superoxide dismutase. Stroke., 2002; 33: 2317-23.
Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Mouse model of
subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol.
Res., 2002; 24: 510-6.
Saito A, Kamii H, Kato I, Takasawa S, Kondo T, Chan PH, Okamoto H, Yoshimoto T.
Transgenic CuZn-superoxide dismutase inhibits NO synthase induction in experimental
subarachnoid hemorrhage. Stroke., 2001; 32: 1652-7.
McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, Pelligrino DA, Warner
DS. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral
vasospasm resulting from subarachnoid hemorrhage. Stroke., 2002; 33: 2950-6.
Lin CL, Calisaneller T, Ukita N, Dumont AS, Kassell NF, Lee KS. A murine model of
subarachnoid hemorrhage-induced cerebral vasospasm. J. Neurosci. Methods, 2003; 123:
89-97.
Altay T, Smithason S, Volokh N, Rasmussen PA, Ransohoff RM, Provencio JJ. A novel
method for subarachnoid hemorrhage to induce vasospasm in mice. J. Neurosci. Methods.,
2009.
14
Feiler et al., Brain damage and ICP after SAH in mice
Kamii H, Kato I, Kinouchi H, Chan PH, Epstein CJ, Akabane A, Okamoto H, Yoshimoto T.
Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice
overexpressing CuZn-superoxide dismutase. Stroke, 1999; 30: 867-71.
McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, Pearlstein RD, Warner DS.
Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing
extracellular superoxide dismutase. Stroke., 2002; 33: 2317-23.
McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, Pelligrino DA, Warner
DS. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral
vasospasm resulting from subarachnoid hemorrhage. Stroke., 2002; 33: 2950-6.
Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Mouse model of
subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol.
Res., 2002; 24: 510-6.
Saito A, Kamii H, Kato I, Takasawa S, Kondo T, Chan PH, Okamoto H, Yoshimoto T.
Transgenic CuZn-superoxide dismutase inhibits NO synthase induction in experimental
subarachnoid hemorrhage. Stroke., 2001; 32: 1652-7.
McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, Pearlstein RD, Warner DS.
Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing
extracellular superoxide dismutase. Stroke., 2002; 33: 2317-23.
McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, Pelligrino DA, Warner
DS. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral
vasospasm resulting from subarachnoid hemorrhage. Stroke., 2002; 33: 2950-6.
Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Mouse model of
subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol.
Res., 2002; 24: 510-6.
15
Feiler et al., Brain damage and ICP after SAH in mice
Liu S, Tang J, Ostrowski RP, Titova E, Monroe C, Chen W, Lo W, Martin R, Zhang JH.
Oxidative stress after subarachnoid hemorrhage in gp91phox knockout mice. Can. J. Neurol.
Sci., 2007; 34: 356-61.
Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa S, Zhang JH. Role of
interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke., 2009;
40: 2519-25.
Liu S, Tang J, Ostrowski RP, Titova E, Monroe C, Chen W, Lo W, Martin R, Zhang JH.
Oxidative stress after subarachnoid hemorrhage in gp91phox knockout mice. Can. J. Neurol.
Sci., 2007; 34: 356-61.
Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa S, Zhang JH. Role of
interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke., 2009;
40: 2519-25.
Liu S, Tang J, Ostrowski RP, Titova E, Monroe C, Chen W, Lo W, Martin R, Zhang JH.
Oxidative stress after subarachnoid hemorrhage in gp91phox knockout mice. Can. J. Neurol.
Sci., 2007; 34: 356-61.
Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa S, Zhang JH. Role of
interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke., 2009;
40: 2519-25.
Thal SC, Plesnila N. Non-invasive intraoperative monitoring of blood pressure and arterial
pCO2 during surgical anesthesia in mice. J. Neurosci. Methods, 2007; 159: 261-7.
Bederson JB, Germano IM, Guarino L. Cortical blood flow and cerebral perfusion pressure in
a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke, 1995; 26: 1086-
91.
16
Feiler et al., Brain damage and ICP after SAH in mice
Kamii H, Kato I, Kinouchi H, Chan PH, Epstein CJ, Akabane A, Okamoto H, Yoshimoto T.
Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice
overexpressing CuZn-superoxide dismutase. Stroke, 1999; 30: 867-71.
Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Mouse model of
subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol.
Res., 2002; 24: 510-6.
Lehmberg J, Beck J, Baethmann A, Uhl E. Influence of the bradykinin B1/B2-receptor-
antagonist B 9430 on the cerebral microcirculation and outcome of gerbils from global
cerebral ischemia. Acta Neurochir. Suppl, 2000; 76: 39-41.
Bermueller C, Thal SC, Plesnila N, Schmid-Elsaesser R, Kreimeier U, Zausinger S.
Hypertonic fluid resuscitation from subarachnoid hemorrhage in rats: a comparison between
small volume resuscitation and mannitol. J. Neurol. Sci., 2006; 241: 73-82.
Barry KJ, Gogjian MA, Stein BM. Small animal model for investigation of subarachnoid
hemorrhage and cerebral vasospasm. Stroke, 1979; 10: 538-41.
Delgado TJ, Brismar J, Svendgaard NA. Subarachnoid haemorrhage in the rat: angiography
and fluorescence microscopy of the major cerebral arteries. Stroke, 1985; 16: 595-602.
Dorsch N, Branston NM, Symon L, Jakubowski J. Intracranial pressure changes following
primate subarachnoid haemorrhage. Neurol. Res., 1989; 11: 201-4.
Lin CL, Calisaneller T, Ukita N, Dumont AS, Kassell NF, Lee KS. A murine model of
subarachnoid hemorrhage-induced cerebral vasospasm. J. Neurosci. Methods, 2003; 123:
89-97.
Altay T, Smithason S, Volokh N, Rasmussen PA, Ransohoff RM, Provencio JJ. A novel
method for subarachnoid hemorrhage to induce vasospasm in mice. J. Neurosci. Methods.,
2009.
17
Feiler et al., Brain damage and ICP after SAH in mice
Kamii H, Kato I, Kinouchi H, Chan PH, Epstein CJ, Akabane A, Okamoto H, Yoshimoto T.
Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice
overexpressing CuZn-superoxide dismutase. Stroke, 1999; 30: 867-71.
Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa S, Zhang JH. Role of
interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke., 2009;
40: 2519-25.
Ishikawa M, Kusaka G, Yamaguchi N, Sekizuka E, Nakadate H, Minamitani H, Shinoda S,
Watanabe E. Platelet and leukocyte adhesion in the microvasculature at the cerebral surface
immediately after subarachnoid hemorrhage. Neurosurgery., 2009; 64: 546-53.
Liu S, Tang J, Ostrowski RP, Titova E, Monroe C, Chen W, Lo W, Martin R, Zhang JH.
Oxidative stress after subarachnoid hemorrhage in gp91phox knockout mice. Can. J. Neurol.
Sci., 2007; 34: 356-61.
McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, Pearlstein RD, Warner DS.
Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing
extracellular superoxide dismutase. Stroke., 2002; 33: 2317-23.
Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Mouse model of
subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol.
Res., 2002; 24: 510-6.
Saito A, Kamii H, Kato I, Takasawa S, Kondo T, Chan PH, Okamoto H, Yoshimoto T.
Transgenic CuZn-superoxide dismutase inhibits NO synthase induction in experimental
subarachnoid hemorrhage. Stroke., 2001; 32: 1652-7.
McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, Pelligrino DA, Warner
DS. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral
vasospasm resulting from subarachnoid hemorrhage. Stroke., 2002; 33: 2950-6.
18
Feiler et al., Brain damage and ICP after SAH in mice
Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent bleeding are
the major causes of death following subarachnoid hemorrhage. Stroke, 1994; 25: 1342-7.
Claassen J, Carhuapoma JR, Kreiter KT, Du EY, Connolly ES, Mayer SA. Global cerebral
edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome.
Stroke, 2002; 33: 1225-32.
Sobey CG, Faraci FM. Subarachnoid haemorrhage: what happens to the cerebral arteries?
Clin. Exp. Pharmacol. Physiol, 1998; 25: 867-76.
Kamii H, Kato I, Kinouchi H, Chan PH, Epstein CJ, Akabane A, Okamoto H, Yoshimoto T.
Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice
overexpressing CuZn-superoxide dismutase. Stroke, 1999; 30: 867-71.
Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa S, Zhang JH. Role of
interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke., 2009;
40: 2519-25.
Ishikawa M, Kusaka G, Yamaguchi N, Sekizuka E, Nakadate H, Minamitani H, Shinoda S,
Watanabe E. Platelet and leukocyte adhesion in the microvasculature at the cerebral surface
immediately after subarachnoid hemorrhage. Neurosurgery., 2009; 64: 546-53.
Liu S, Tang J, Ostrowski RP, Titova E, Monroe C, Chen W, Lo W, Martin R, Zhang JH.
Oxidative stress after subarachnoid hemorrhage in gp91phox knockout mice. Can. J. Neurol.
Sci., 2007; 34: 356-61.
McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, Pearlstein RD, Warner DS.
Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing
extracellular superoxide dismutase. Stroke., 2002; 33: 2317-23.
19
Feiler et al., Brain damage and ICP after SAH in mice
Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Mouse model of
subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol.
Res., 2002; 24: 510-6.
Saito A, Kamii H, Kato I, Takasawa S, Kondo T, Chan PH, Okamoto H, Yoshimoto T.
Transgenic CuZn-superoxide dismutase inhibits NO synthase induction in experimental
subarachnoid hemorrhage. Stroke., 2001; 32: 1652-7.
McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, Pelligrino DA, Warner
DS. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral
vasospasm resulting from subarachnoid hemorrhage. Stroke., 2002; 33: 2950-6.
Kamii H, Kato I, Kinouchi H, Chan PH, Epstein CJ, Akabane A, Okamoto H, Yoshimoto T.
Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice
overexpressing CuZn-superoxide dismutase. Stroke, 1999; 30: 867-71.
McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, Pearlstein RD, Warner DS.
Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing
extracellular superoxide dismutase. Stroke., 2002; 33: 2317-23.
McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, Pelligrino DA, Warner
DS. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral
vasospasm resulting from subarachnoid hemorrhage. Stroke., 2002; 33: 2950-6.
Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Mouse model of
subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol.
Res., 2002; 24: 510-6.
Saito A, Kamii H, Kato I, Takasawa S, Kondo T, Chan PH, Okamoto H, Yoshimoto T.
Transgenic CuZn-superoxide dismutase inhibits NO synthase induction in experimental
subarachnoid hemorrhage. Stroke., 2001; 32: 1652-7.
20
Feiler et al., Brain damage and ICP after SAH in mice
McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, Pearlstein RD, Warner DS.
Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing
extracellular superoxide dismutase. Stroke., 2002; 33: 2317-23.
McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, Pelligrino DA, Warner
DS. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral
vasospasm resulting from subarachnoid hemorrhage. Stroke., 2002; 33: 2950-6.
Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Mouse model of
subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol.
Res., 2002; 24: 510-6.
Liu S, Tang J, Ostrowski RP, Titova E, Monroe C, Chen W, Lo W, Martin R, Zhang JH.
Oxidative stress after subarachnoid hemorrhage in gp91phox knockout mice. Can. J. Neurol.
Sci., 2007; 34: 356-61.
Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa S, Zhang JH. Role of
interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke., 2009;
40: 2519-25.
Liu S, Tang J, Ostrowski RP, Titova E, Monroe C, Chen W, Lo W, Martin R, Zhang JH.
Oxidative stress after subarachnoid hemorrhage in gp91phox knockout mice. Can. J. Neurol.
Sci., 2007; 34: 356-61.
Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa S, Zhang JH. Role of
interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke., 2009;
40: 2519-25.
Liu S, Tang J, Ostrowski RP, Titova E, Monroe C, Chen W, Lo W, Martin R, Zhang JH.
Oxidative stress after subarachnoid hemorrhage in gp91phox knockout mice. Can. J. Neurol.
Sci., 2007; 34: 356-61.
21
Feiler et al., Brain damage and ICP after SAH in mice
Sozen T, Tsuchiyama R, Hasegawa Y, Suzuki H, Jadhav V, Nishizawa S, Zhang JH. Role of
interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke., 2009;
40: 2519-25.
Schwartz AY, Masago A, Sehba FA, Bederson JB. Experimental models of subarachnoid
hemorrhage in the rat: a refinement of the endovascular filament model. J. Neurosci.
Methods, 2000; 96: 161-7.
Schubert GA, Seiz M, Hegewald AA, Manville J, Thome C. Acute hypoperfusion immediately
after subarachnoid hemorrhage: a xenon contrast-enhanced CT study. J. Neurotrauma,
2009; 26: 2225-31.
22
Feiler et al., Brain damage and ICP after SAH in mice
FIGURE LEGENDS
Figure 1
Time course of ICP (A), mean arterial blood pressure (B), cerebral perfusion pressure (C),
and rCBF (D) before and after induction of SAH in mice by perforation of the Circulus of
Willis by an intraluminal filament (CWp; n=8). CWp results in a uniform distribution of blood in
the subarachnoid space (E). Monitoring the induction of SAH by rCBF alone may result in
false positive results since advancement of the filament into the Circulus of Willis may result
in a reduction of rCBF without vessel perforation as indicated by the lack of ICP increase (F).
Figure 2
Mortality during the first 7 days after CWp (A; n=10). Brain water content (B) and intracranial
pressure (ICP; n=6; C) 24 and 72 hours after murine SAH.
Figure 3
Brain damage 7 days after SAH by CWp in mice. Neuronal cell death is observed bilaterally
in the hippocampus (A & B) while the cortex and the striatum are not significantly affected
(C).
Figure 4:
Functional outcome following SAH in mice by CWp (n=6). Neuroscore performance is
significantly altered during the first three days after SAH but recovers thereafter ( A), while
body weight reduces gradually during the same period of time and shows only little recovery
(B).
23
Feiler et al., Brain damage and ICP after SAH in mice
Table 1
24
pH pCO pO HCO3- Na+KCa2++ Cl
SAH 7.3 ±
0.02
±82.0 ±
10.7
±144.5 ± ± 1.3
±
0.03
112.7 ±
Sham 7.28
±
0.02
± ±
22.6
20.2 ±154.7 ±
2.2
4.9 ±
0.4
1.3 ±
0.01
113.1 ±
1.3
pH pCO2pO2Na K+Cl-
SAH 7.30
0.02
41.8 ±
3.5
±
10.7
20.2 ±
1.2
±
1.9
4.6 ±
0.2
1.3
±
0.03
±
1.1
Sham 7.28
±
0.02
43.8 ±
5.6
80.0 ±
22.6
±
2.1
± ± ±
0.01
±
Physiological parameters 30 min after SAH
Feiler et al., Brain damage and ICP after SAH in mice
Table 2
25
Neuroscore
Item Points Best Worse
Grasp Reflex (1) per paw, if
missing 0 4
Righting Reflexes
orienting the head (2) per side, if
missing 0 4
falling reflex (1) if missing 0 1
Mobility
spontaneous
(0) normal
(4) intermediate
(8) missing
0 8
circling (2) if present 0 2
Fur (0) smooth
(4) fuzzy 0 4
Nibbling
(0) normal
(4) intermediate
(8) missing
0 8
Flight (0) normal
(2) missing 0 2
Total 0 33
Item Points Best Worse
Grasp Reflex (1) per paw, if
missing 0 4
Righting Reflexes
orienting the head (2) per side, if
missing 0 4
falling reflex (1) if missing 0 1
Mobility
(0) normal
(4) intermediate
(8) missing
0 8
circling (2) if present 0 2
Fur (0) smooth
(4) fuzzy 0 4
Nibbling
(0) normal
intermediate
(8) missing
0 8
Flight 0 2